Biotechnology
Hims & Hers Stock Soars After Strategic Partnership With Novo Nordisk
Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims & Hers Health (HIMS)...
IBM, AMD, Novo Nordisk Lead Midday Market Movers
Tech, retail, and healthcare stocks drive volatility as investors react to earnings and AI trends Several major stocks posted notable...
Vanda Pharmaceuticals Gains on FDA Approval of BYSANTI
Regulatory green light strengthens commercial outlook and expands product portfolio Shares of Vanda Pharmaceuticals (VNDA) moved higher after the company...
Gilead Sciences to Acquire Arcellx, Sending Shares Higher
Biotech deal signals strategic expansion in next-generation cell therapies Shares of Arcellx (ACLX) moved higher following the announcement that the...
Moderna’s Flu Vaccine Back Under FDA Review After Key Modifications
Regulatory reversal boosts investor confidence and puts mRNA flu shot on track for potential approval this year Moderna (MRNA) has...
FDA Approves Novocure’s Optune Pax®, Marking Major Breakthrough in Pancreatic Cancer Treatment
First new therapy in nearly 30 years delivers survival benefit using innovative electric field technology The U.S. Food and Drug...
Viking Therapeutics Moves Oral Obesity Drug Into Late-Stage Development
Company advances VKTX program as competition intensifies in the rapidly expanding weight-loss market Viking Therapeutics (VKTX) announced Wednesday that it...
Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS)...
Serina Therapeutics Advances Parkinson’s Program After Key FDA Green Light
IND clearance positions SER-252 for clinical progress in advanced Parkinson’s disease treatment Serina Therapeutics (SER) announced a significant regulatory milestone...
AI Is Already Transforming Drug Development—Just Not Where Investors Expected
While “AI-discovered” breakthrough medicines are still emerging, pharma is using AI today to cut costs, speed trials, and reduce regulatory...
